1. Introduction {#sec1}
===============

A lively discussion exists about the question as to how much of conventional medicine might be based on sound evidence \[[@B1]\]. One figure that is often cited is 15% \[[@B2]\]. It presents, however, unreliable and out-dated information: the figure can be traced back to a small survey conducted in 1960/61 of prescribing practises of family doctors in a northern British town, which looked toward controlling prescribing costs \[[@B3]\]. Other experts have published more convincing data showing that an average of 76% of interventions are supported by some form of compelling evidence, with an average of 37% of interventions being supported by randomized clinical trials (RCTs) \[[@B3]\]. A recent systematic review \[[@B4]\] of the topic found that, in general internal medicine, over 50% \[[@B5]\] and in psychiatry over 65% \[[@B6]\] of interventions are based on positive data from RCTs.

The discussion about the evidence-base of CAM is far less lively. Here I present a first attempt to generate some data and hopefully a constructive discussion on this potentially important subject.

2. Methods {#sec2}
==========

As a basis for my assessment, I used our own book *The Desktop Guide to Complementary and Alternative Medicine* \[[@B6]\]. In this book, we evaluate the research evidence from clinical trials and systematic reviews as it pertains to any type of CAM for a wide range of conditions (*n* = 46). For each condition, we compiled a "summary of clinical evidence" table in which the treatments are categorized according to the "weight" and "direction" of the evidence. The "weight" is conceptualized as a composite measure of the quantity, quality and level of the research evidence, which refers to the confidence that can be placed on that evidence \[[@B6]\]. The quantity refers to the total patient sample included in all clinical trials---there could, for instance, be five studies with an average of 20 patients resulting in a total sample of 100; this would be less than a single study with a sample of 300. The quality of the trial evidence refers to the likelihood of bias, usually estimated with a score such as the Jadad score \[[@B7]\]. The level of the evidence refers to the hierarchy of research evidence where systematic reviews are on top and opinion or anecdotal evidence at the bottom. The "direction" of the evidence signals whether the effect is clearly positive, tentatively positive, uncertain, tentatively negative or clearly negative \[[@B6]\]. The book has a full methods section to maximize transparency and reproducibility. It describes our assessments in more detail \[[@B6]\].

For the purpose of this analysis, I have simply counted the number of treatments which obtained the maximum "weight" and also were rated as "clearly positive" in our "summary of clinical evidence" tables. This provided the number of treatments that are supported by good evidence (if one therapy was effective for two indications it was counted twice). Subsequently, this figure was put in relation to the total number of treatment/condition pairings from all the "summary of clinical evidence" tables in our book \[[@B6]\].

3. Results {#sec3}
==========

Fifty-one treatments were characterized as having maximum "weight" of evidence as well as being "clearly positive." The total number of treatment/condition pairings was 685. Consequently, 7.4% of them were based on sound evidence. [Table 1](#tab1){ref-type="table"} provides a list of these 51 treatment/condition pairings.

4. Discussion {#sec4}
=============

The estimate that 7.4% of CAM is based on sound evidence may well be over-optimistic. We selected the conditions for inclusion in our book \[[@B6]\] on the basis of two main criteria: first, the condition had to be relevant, that is, commonly seen in primary care or frequently treated with CAM and/or there had to be sufficient trial data to write a chapter. Thus, this evidence summarized in the present article represents a positive selection. Had we chosen different conditions for our book, the percentage would most likely have been lower.

A glance at [Table 1](#tab1){ref-type="table"} furthermore informs us that several of the included modalities, for example, exercise, group behaviour therapy, stress management, fiber intake or biofeedback, could easily be classified as conventional interventions rather than CAM. Had we excluded them, the percentage of evidence-based CAM would have declined further.

Finally, several cases of "sound" evidence included in [Table 1](#tab1){ref-type="table"} might need revision in the light of evidence that has emerged since the publication of our book. Examples include saw palmetto (*Serenoa repens*) \[[@B8]\], glucosamine \[[@B9]--[@B12]\], *Ginkgo biloba* \[[@B13]--[@B16]\] and acupuncture which, according to recent findings, may not be more efficacious than sham acupuncture \[[@B17], [@B18]\].

Another concern is that the present analysis merely relates to the question of how many therapies might be supported by sound research evidence. It does not address the question of how solidly CAM practice is evidence-based. This would require an assessment of which treatments are used and how often. Such a research project would be complex but would certainly be a valuable contribution to the literature.

Although my estimate of how much of CAM is evidence-based draws on a critical evaluation of the available evidence, it still presents a rather optimistic view. Further investigations into this subject are required to arrive at more representative figures.

###### 

CAM treatments based on sound evidence.

  Intervention              Conditions
  ------------------------- -----------------------------------------------
  Acupuncture               Nausea/vomiting induced by chemotherapy
  Acupuncture               Osteoarthritis
  African plum              Benign prostatic hyperplasia
  Allium vegetables         Cancer prevention
  Aromatherapy/massage      Cancer palliation
  Biofeedback               Hypertension
  Biofeedback               Migraine
  Chondroitin               Osteoarthritis
  Co-enzyme Q10             Hypertension
  Diet                      Rheumatoid arthritis
  Ephedra sinica            Overweight
  Exercise                  Cancer prevention
  Exercise                  Cancer palliation
  Exercise                  Chronic fatigue syndrome
  Exercise                  Depression
  Exercise                  HIV/AIDS
  Fiber                     Irritable bowel syndrome
  Ginkgo biloba             Alzheimer\'s disease
  Ginkgo biloba             Peripheral vascular disease
  Glucosamine               Osteoarthritis
  Green tea                 Cancer prevention
  Group behaviour therapy   Smoking cessation
  Guar gum                  Diabetes
  Guar gum                  Hypercholesterolemia
  Hawthorn                  Chronic heart failure
  Horse chestnut            Chronic venous insufficiency
  Hypnotherapy              Labor pain
  Kava                      Anxiety
  Massage                   Anxiety
  Melatonin                 Insomnia
  Music therapy             Anxiety
  Oat                       Hypercholesterolemia
  Padma 28                  Peripheral vascular disease
  Peppermint/caraway        Non-ulcer dyspepsia
  Phytodolor                Osteoarthritis
  Phytodolor                Rheumatoid arthritis
  Psyllium                  Constipation
  Psyllium                  Diabetes
  Red clover                Menopause
  Relaxation                Anxiety
  Relaxation                Insomnia
  Relaxation                Nausea/vomiting induced by chemotherapy
  *S*-adenosylmethionine    Osteoarthritis
  Saw palmetto              Benign prostatic hyperplasia
  Soy                       Hypercholesterolemia
  St John\'s wort           Depression
  Stress management         HIV/AIDS
  Tomato (lycopene)         Cancer prevention
  Vitamin C                 Upper respiratory tract infection (treatment)
  Water immersion           Labor pain
  Yohimbine                 Erectile dysfunction
